Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Neurotoxicology. 2020 Jan 30;77:216–230. doi: 10.1016/j.neuro.2020.01.012

Table 2.

Descriptive characteristics for 124 participants used to determine associations between post-exposure performance (Sessions 4 and 5) and demographic characteristics or measures of exposure from earlier Sessions (2 and 3) when CPF application was ongoing.

Characteristic Applicator (n = 30) Technician (n = 47) Engineer (n = 47) p-value
Trails A, s mean (SD) 83.2 (31.8) 76.7 (16.9) 78.7 (50.3) 0.60
Trails B, s mean (SD) 168.1 (52.2) 171.4 (36.8) 152.9 (44.0) 0.09
Age, yrs mean (SD) 38.9 (13.5) 48.7 (4.6) 54.1 (4.3) <0.001
Education, yrs mean (SD) 11.0 (2.3) 12.3 (1.2) 14.5 (3.0) <0.001
Years MOA mean (SD) 12.9 (9.2) 14.7 (9.4) 18.5 (8.3) 0.02
GMa TCPy, ng/mg creat. median [IQR] 20.8 [11.8–50.3] 12.5 [7.8–20.2] 12.1 [8.9–20.6] 0.03
Relativeb AChE median [IQR] 0.98 [0.93–1.01] 0.98 [0.95–1.01] 0.97 [0.94–1.00] 0.63
Relativeb BuChE median [IQR] 0.86 [0.68–0.94] 0.94 [0.86–1.00] 0.94 [0.90–0.99] 0.01
a

Geometric mean from Session 2 & 3.

b

Geometric mean activity from Session 2 & 3, divided by activity at Session 1.